Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention

Published:2019-04 Issue:4 Volume:12 Page:
ISSN:1941-7640
Container-title:Circulation: Cardiovascular Interventions
language:en
Short-container-title:Circ: Cardiovascular Interventions

Author:

Faggioni Michela¹²,Baber Usman¹,Sartori Samantha¹,Chandrasekhar Jaya¹,Cohen David J.³,Henry Timothy D.⁴,Claessen Bimmer E.¹,Dangas George D.¹,Gibson C. Michael⁵,Krucoff Mitchell W.⁶,Vogel Birgit¹,Moliterno David J.⁷,Sorrentino Sabato¹,Colombo Antonio⁸,Chieffo Alaide⁸,Kini Annapoorna¹,Farhan Serdar¹,Ariti Cono⁹,Witzenbichler Bernard¹⁰,Weisz Giora¹¹,Steg Philippe Gabriel¹²,Pocock Stuart⁹,Mehran Roxana¹

Affiliation:

1. Center for Interventional Cardiovascular Research and Clinical Trials, The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York City, NY (M.F., U.B., S. Sartori, J.C., B.E.C., G.D., B.V., S. Sorrentino, A.K., S.F., R.M.).

2. Department of Internal Medicine, James J. Peters Veterans Affairs Medical Center, Bronx, NY (M.F.).

3. Department of Internal Medicine, Section: Cardiovascular Disease, St. Luke’s Mid America Heart Institute, University of Missouri-Kansas City (D.J.C.).

4. Division of Cardiology, Cedars-Sinai Heart Institute, Los Angeles, CA (T.D.H.).

5. Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, MA (C.M.G.).

6. Department of Internal Medicine, Duke University School of Medicine, Durham, NC (M.W.K.).

7. Gill Heart Institute and Division of Cardiovascular Medicine, University of Kentucky, Lexington (D.J.M.).

8. Cardio-Thoracic Department, San Raffaele Scientific Institute, Milan, Italy (A. Colombo, A. Chieffo).

9. Department of Medical Statistics, London School of Hygiene and Tropical Medicine, United Kingdom (C.A., S.P.).

10. Department of Cardiology and Pneumology, Helios Amper-Klinikum, Dachau, Germany (B.W.).

11. Clinical Trials Center, Cardiovascular Research Foundation, New York, New York; Montefiore Medical Center, Bronx, New York (G.W.).

12. Département Hospitalo-Universitaire (DHU) Fibrose Inflammation Remodelage (FIRE), University Paris Diderot, Assistance Publique - Hôpitaux de Paris (AP-HP), INSERM U-1148, France (P.G.S.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference18 articles.

1. Evaluation and management of anemia in the elderly

2. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention

3. Impact of Anemia on Clinical Outcomes of Patients With ST-Segment Elevation Myocardial Infarction in Relation to Gender and Adjunctive Antithrombotic Therapy (from the HORIZONS-AMI Trial)

4. Meta-Analysis of the Prognostic Impact of Anemia in Patients Undergoing Percutaneous Coronary Intervention

5. Effect of Anemia on Frequency of Short- and Long-Term Clinical Events in Acute Coronary Syndromes (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial)

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The importance of intensive follow-up and achieving optimal chronic antithrombotic treatment in hospitalized medical patients with anemia: a prospective cohort study;Hellenic Journal of Cardiology;2024-01

2. The prevalence of bleeding after percutaneous coronary interventions: Systematic review and meta-analysis;Indian Heart Journal;2024-01

3. Transfusion thresholds in acute coronary syndromes;Current Opinion in Cardiology;2023-08-17

4. Non-ST Elevation Myocardial Infarction in the Elderly. Antithrombotic Therapy and Beyond;Reviews in Cardiovascular Medicine;2023-07-13

5. Incidence and impact of antiplatelet therapy cessation among very older patients with stable coronary artery disease;Frontiers in Pharmacology;2023-06-05